In an exclusive interview, the singer discusses his new leading role in 'Cabaret,' the 'American Idol' Season 8 group chat ...

Vinegar is a natural cleaning solution that yields numerous benefits in and around your home—and it's so cheap!

On October 11th, 2017, YouTuber BlueEyes uploaded a parody of the opening sequence featuring the "Sasageyo!" scene from Attack on Titan (shown below, left). Within three weeks, the video received ...

More than 21,000 candidates have taken Ballotpedia's candidate survey since we launched it in 2015. Learn more about the survey here. You can ask Elmer W. Bull to fill out this survey by using the ...

Indie horror comedy “Glue Trap” has been acquired by Gravitas Ventures following a film festival run that began with its premiere last year at Dances With Films. The film, written and directed ...

NEW BRITAIN, CT (WFSB) - Elmer’s Place, a beloved bar and restaurant located at 1433 East Street in New Britain, has officially changed hands. Situated directly across from Central Connecticut ...

If you click on a link in this story we may earn affiliate revenue. M&S shoppers have been going wild for a £6 room spray that they say is "the smell of Christmas". The posh shop has released ...

A Shrewsbury couple are warning others against using spray foam insulation without first making absolutely sure that it is appropriate as they face a £50,000 bill to repair the damage.

“He was the glue. Once he passed, it’s been pretty hard.” Carlos Sr. sees his granddaughter less now. The rest of the family isn’t as quick to gather for a barbecue without Carlos Jr ...

The Boston-based biotech is having a ball after signing a deal with Novartis to the tune of $150 million for a molecular glue degrader, developed using the company’s QuEEN platform, that makes ...

The molecular glue degrader medicines furthest along in development are potential cancer treatments, but Monte Rosa Therapeutics is also researching how this therapeutic modality can treat ...

Novartis will apply Monte Rosa Therapeutics’ target discovery platform to develop its T and B cell-modulating molecular glue degraders targeting the VAV1 protein—starting with its Phase I ...